Journal list menu
- Issue
Alzheimer's & Dementia: Volume 19, Issue 12
5325-5993December 2023
Export Citations
ISSUE INFORMATION
RESEARCH ARTICLES
Open Access
oa
Validation of newly derived polygenic risk scores for dementia in a prospective study of older individuals
- Pages: 5333-5342
- First Published: 12 May 2023
Open Access
oa
Plasma and CSF concentrations of N-terminal tau fragments associate with in vivo neurofibrillary tangle burden
- Pages: 5343-5354
- First Published: 15 May 2023
Open Access
oa
Preserved autophagy in cognitively intact non-demented individuals with Alzheimer's neuropathology
- Pages: 5355-5370
- First Published: 16 May 2023
Open Access
oa
Differential effects of sleep on brain structure and metabolism at the preclinical stages of AD
- Pages: 5371-5386
- First Published: 17 May 2023
Open Access
oa
Design and feasibility of an Alzheimer's disease blood test study in a diverse community-based population
- Pages: 5387-5398
- First Published: 19 May 2023
Open Access
oa
How intention to join an Alzheimer's participant recruitment registry differs by race, ethnicity, sex, and family history: Results from a national survey of US adults
- Pages: 5399-5406
- First Published: 19 May 2023
Open Access
oa
APOE ε4's impact on response to amyloid therapies in early symptomatic Alzheimer's disease: Analyses from multiple clinical trials
- Pages: 5407-5417
- First Published: 19 May 2023
Open Access
oa
Alzheimer's disease brain-derived extracellular vesicles reveal altered synapse-related proteome and induce cognitive impairment in mice
- Pages: 5418-5436
- First Published: 19 May 2023
Open Access
oa
Leveraging African American family connectors for Alzheimer's disease genomic studies
- Pages: 5437-5446
- First Published: 22 May 2023
Open Access
oa
Large-scale proteome and metabolome analysis of CSF implicates altered glucose and carbon metabolism and succinylcarnitine in Alzheimer's disease
- Pages: 5447-5470
- First Published: 22 May 2023
Open Access
oa
Weight loss and risk of dementia in individuals with versus without obesity
- Pages: 5471-5481
- First Published: 22 May 2023
Open Access
oa
Amisulpride as a potential disease-modifying drug in the treatment of tauopathies
- Pages: 5482-5497
- First Published: 23 May 2023
Open Access
oa
DementiaNet facilitates a sustainable transition toward integrated primary dementia care: A long-term evaluation
- Pages: 5498-5505
- First Published: 23 May 2023
Open Access
oa
Predicting amyloid-beta pathology in the general population
- Pages: 5506-5517
- First Published: 11 June 2023
Open Access
oa
Change in lipids before onset of dementia, coronary heart disease, and mortality: A 28-year follow-up Whitehall II prospective cohort study
- Pages: 5518-5530
- First Published: 27 May 2023
Open Access
oa
Levels of Alzheimer's disease blood biomarkers are altered after food intake—A pilot intervention study in healthy adults
- Pages: 5531-5540
- First Published: 27 May 2023
Open Access
oa
Association of ischemic heart disease with long-term risk of cognitive decline and dementia: A cohort study
- Pages: 5541-5549
- First Published: 30 May 2023
Open Access
oa
Novel loci for Alzheimer's disease identified by a genome-wide association study in Ashkenazi Jews
- Pages: 5550-5562
- First Published: 01 June 2023
Open Access
oa
Fc N-glycosylation of autoreactive Aβ antibodies as a blood-based biomarker for Alzheimer's disease
- Pages: 5563-5572
- First Published: 01 June 2023
Open Access
oa
Higher concentrations of kynurenic acid in CSF are associated with the slower clinical progression of Alzheimer's disease
- Pages: 5573-5582
- First Published: 02 June 2023
Open Access
oa
Rare neurovascular genetic and imaging markers across neurodegenerative diseases
- Pages: 5583-5595
- First Published: 05 June 2023
Open Access
oa
Preparedness of China's health care system to provide access to a disease-modifying Alzheimer's treatment
- Pages: 5596-5604
- First Published: 06 June 2023
Open Access
oa
Profiling and predicting distinct tau progression patterns: An unsupervised data-driven approach to flortaucipir positron emission tomography
- Pages: 5605-5619
- First Published: 08 June 2023
Open Access
oa
Longitudinal blood biomarker trajectories in preclinical Alzheimer's disease
- Pages: 5620-5631
- First Published: 09 June 2023
Open Access
oa
White matter hyperintensity shape is associated with long-term dementia risk
- Pages: 5632-5641
- First Published: 12 June 2023
Open Access
oa
Early β-amyloid accumulation in the brain is associated with peripheral T cell alterations
- Pages: 5642-5662
- First Published: 14 June 2023
Open Access
oa
Use of the patient portal among older adults with diagnosed dementia and their care partners
- Pages: 5663-5671
- First Published: 24 June 2023
Open Access
oa
Serum NfL and GFAP are associated with incident dementia and dementia mortality in older adults: The cardiovascular health study
- Pages: 5672-5680
- First Published: 01 July 2023
Open Access
oa
Dementia risk in patients with type 2 diabetes: Comparing metformin with no pharmacological treatment
- Pages: 5681-5689
- First Published: 03 July 2023
Open Access
oa
A simulative deep learning model of SNP interactions on chromosome 19 for predicting Alzheimer's disease risk and rates of disease progression
- Pages: 5690-5699
- First Published: 06 July 2023
Open Access
oa
Physical activity, biomarkers of brain pathologies and dementia risk: Results from the Memento clinical cohort
- Pages: 5700-5718
- First Published: 08 July 2023
Open Access
oa
Effects of amyloid beta and dopaminergic depletion on perfusion and clinical symptoms
- Pages: 5719-5729
- First Published: 08 July 2023
Open Access
oa
Prevalence and impact of neuropsychiatric symptoms in normal aging and neurodegenerative syndromes: A population-based study from Latin America
- Pages: 5730-5741
- First Published: 10 July 2023
Open Access
oa
Associations of dietary cholesterol and fat, blood lipids, and risk for dementia in older women vary by APOE genotype
- Pages: 5742-5754
- First Published: 12 July 2023
Open Access
oa
Plasma NT1-tau and Aβ42 correlate with age and cognitive function in two large Down syndrome cohorts
- Pages: 5755-5764
- First Published: 12 July 2023
Open Access
oa
Trans-ethnic genomic informed risk assessment for Alzheimer's disease: An International Hundred K+ Cohorts Consortium study
- Pages: 5765-5772
- First Published: 14 July 2023
REVIEW ARTICLES
Open Access
oa
Impact of sharing Alzheimer's disease biomarkers with individuals without dementia: A systematic review and meta-analysis of empirical data
- Pages: 5773-5794
- First Published: 26 July 2023
Open Access
oa
Therapeutic strategies in vascular cognitive impairment: A systematic review of population, intervention, comparators, and outcomes
- Pages: 5795-5804
- First Published: 04 August 2023
Open Access
oa
The potential clinical value of plasma biomarkers in Alzheimer's disease
- Pages: 5805-5816
- First Published: 11 September 2023
PERSPECTIVES
Open Access
oa
Gaps in clinical research in frontotemporal dementia: A call for diversity and disparities–focused research
- Pages: 5817-5836
- First Published: 03 June 2023
Open Access
oa
The intersection of social determinants of health and family care of people living with Alzheimer's disease and related dementias: A public health opportunity
- Pages: 5837-5846
- First Published: 12 September 2023
LETTERS
Open Access
oa
Antidepressants and the risk of bleeding in the era of anti-amyloid drugs
- Pages: 5847-5848
- First Published: 16 August 2023
Open Access
oa
Inadequate reimbursement for lumbar puncture is a potential barrier to accessing new Alzheimer's disease treatments
- Pages: 5849-5851
- First Published: 18 September 2023
SHORT REPORT
Open Access
oa
Health care utilization and costs in the years preceding dementia identification
- Pages: 5852-5859
- First Published: 18 September 2023
SPECIAL SECTION: THE FUTURE OF ARTIFICIAL INTELLIGENCE IN THE FIELD OF DEMENTIA. GUEST EDITORS: PROF. DAVID LLEWELLYN, UNIVERSITY OF EXETER AND THE ALAN TURING INSTITUTE; AND DR. JANICE RANSON, UNIVERSITY OF EXETER
Artificial Intelligence
Open Access
oa
Artificial intelligence for biomarker discovery in Alzheimer's disease and dementia
- Pages: 5860-5871
- First Published: 31 August 2023
Open Access
oa
Artificial intelligence for dementia—Applied models and digital health
- Pages: 5872-5884
- First Published: 26 July 2023
Open Access
oa
Artificial intelligence for diagnostic and prognostic neuroimaging in dementia: A systematic review
- Pages: 5885-5904
- First Published: 10 August 2023
Open Access
oa
Artificial intelligence for dementia genetics and omics
- Pages: 5905-5921
- First Published: 22 August 2023
Open Access
oa
Artificial intelligence for dementia drug discovery and trials optimization
- Pages: 5922-5933
- First Published: 16 August 2023
Open Access
oa
Artificial intelligence for dementia research methods optimization
- Pages: 5934-5951
- First Published: 28 August 2023
Open Access
oa
Artificial intelligence for dementia prevention
- Pages: 5952-5969
- First Published: 14 October 2023
Open Access
oa
Artificial intelligence for neurodegenerative experimental models
- Pages: 5970-5987
- First Published: 28 September 2023
THIS ARTICLE HAS BEEN RETRACTED AND IS AVAILABLE ONLINE ONLY
no
Retracted: Ultra-processed food consumption and risk of dementia and Alzheimer's disease: Long-term results from the Framingham Offspring Study
- Pages: 5988
- First Published: 03 July 2023